Fluorinated 4-azasteroids as androgen receptor modulators

Details for Australian Patent Application No. 2005237501 (hide)

Owner Merck & Co., Inc.

Inventors Perkins, James J.; Meissner, Robert S.

Agent Spruson & Ferguson

Pub. Number AU-A-2005237501

PCT Pub. Number WO2005/105091

Priority 60/566,044 28.04.04 US

Filing date 22 April 2005

Wipo publication date 10 November 2005

International Classifications

A61K 31/437 (2006.01)

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105091 Priority application(s): WO2005/105091

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005237505-Prop-jet

2005237500-3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity